Wissens- und Technologietransfer in öffentlichen Forschungseinrichtungen

Der Artikel analysiert die Strukturen und Prozesse des Transfers von Wissen und Technologie in deutschen Forschungseinrichtungen und findet Ansatzpunkte für eine Intensivierung der Transfertätigkeit in der Wissenschaft.Deutschland, Wissenstransfer, Technologietransfer, Forschungsinstitut, Finanzierung

China’s technological performance as reflected in patents

Various concepts for the comparison of countries by patent indicators have been developed for the comparison of countries based on patent indicators. These concepts are generally based on the application of patents in several important markets or the family size of patent applications. A specific observation is the limited transfer of PCT applications of Chinese origin, affecting all these concepts. Transnational patents prove to be a convenient and appropriate tool for making country comparisons by technology, particularly with respect to adequately consider China’s specific patent behaviour. Therefore the phenomenon of limited transfer of China’s PCT applications is analysed for transnational patents. This observation can be associated with lower patent values or with a decreasing export dynamic. The Chinese transfer rates vary considerably by technology as well as by the reason for lower transfer rates. It proves to be more adequate to take limited transfer rates into account. © 2021, The Author(s)

Zur Bedeutung der angewandten Grundlagenforschung : Ergebnisse einer schriftlichen Befragung bei Fraunhofer-Instituten

--

Governance der Kooperation heterogener Partner im deutschen Forschungs- und Innovationssystem

--

International patent applications and innovation in South Africa

BACKGROUND: Experts recommend support to patents for stimulating innovation. Also, the South African government supports patents, in particular, international patents. In this paper it is examined how this strategy can be designed to successfully trigger economic progress AIM: The present South African activities in patents are investigated in this paper and areas identified where an intensification of patenting looks promising for economic progress SETTING: The patent activities since 1985 are analysed and compared to the annual export-import balance from 2009 to 2018, in order to identify starting points for improving economic structures. The data are linked to current suggestions to the National Advisory Council on Innovation (NACI) for future technologies METHODS: The analysis of patents is performed, using the international patent database PATSTAT, as well as the analysis of the export-import balance at the WITS database of the World Bank RESULTS: The patent analysis reveals a low level of South African domestic patents, with a focus on less complex goods and a stagnation period of 35 years. The data on the export - import balance show negative figures for consumer goods and even more so for capital goods CONCLUSION: Economic progress can be accelerated by stimulating patent and economic activities to produce more complex consumer and capital goods. However, it may be necessary to focus on certain areas at the beginning in order to achieve a sufficient critical mass of competence and international competitiveness. In any case, the support of patents is only successful when it is closely linked to a strategy regarding technology.https://sajems.org/index.php/sajemsInstitute for Technological Innovation (ITI

Artificial intelligence in human genomics and biomedicine - Dynamics, potentials and challenges

The increasing availability of extensive and complex data has made human genomics and its applications in (bio)medicine an at­ tractive domain for artificial intelligence (AI) in the form of advanced machine learning (ML) methods. These methods are linked not only to the hope of improving diagnosis and drug development. Rather, they may also advance key issues in biomedicine, e. g. understanding how individual differences in the human genome may cause specific traits or diseases. We analyze the increasing convergence of AI and genom­ics, the emergence of a corresponding innovation system, and how these associative AI methods relate to the need for causal knowledge in biomedical research and development (R&D) and in medical prac­tice. Finally, we look at the opportunities and challenges for clinical practice and the implications for governance issues arising from this convergence.Die zunehmende Verfügbarkeit umfangreicher und komplexer Daten hat die Humangenomik und ihre Anwendungsbereiche in der (Bio-)Medizin zu einem attraktiven Bereich für künstliche Intelligenz (KI) vor allem in Form von fortgeschrittenen Methoden des maschinellen Lernens (ML) gemacht. Diese Methoden sind nicht nur mit der Hoffnung verbunden, Diagnosen und die Medikamentenentwicklung zu verbessern. Sie könnten auch darum, Kernthemen in der Biomedizin voranzubringen, z. B. zu verstehen, wie individuelle Unterschiede im menschlichen Genom bestimmte Merkmale oder Krankheiten verursachen können. Wir analysieren die zunehmende Konvergenz von KI und Genomik, das Entstehen eines entsprechenden Innovationssystems und wie diese assoziativen KI‑Methoden mit dem Bedarf an kausalem Wissen in der biomedizinischen Forschung und Entwicklung und in der medizinischen Praxis zusammenhängen. Schließlich betrachten wir die Potenziale und Herausforderungen für die klinische Praxis und die sich aus dieser Konvergenz ergebenden Implikationen für Governance-Fragen

Is Inequality Among Universities Increasing? Gini Coefficients and the Elusive Rise of Elite Universities

One of the unintended consequences of the New Public Management (NPM) in universities is often feared to be a division between elite institutions focused on research and large institutions with teaching missions. However, institutional isomorphisms provide counter-incentives. For example, university rankings focus on certain output parameters such as publications, but not on others (e.g., patents). In this study, we apply Gini coefficients to university rankings in order to assess whether universities are becoming more unequal, at the level of both the world and individual nations. Our results do not support the thesis that universities are becoming more unequal. If anything, we predominantly find homogenization, both at the level of the global comparisons and nationally. In a more restricted dataset (using only publications in the natural and life sciences), we find increasing inequality for those countries, which used NPM during the 1990s, but not during the 2000s. Our findings suggest that increased output steering from the policy side leads to a global conformation to performance standards

Structure du système de recherche et d’innovation allemand : spécificités et appréciation

Conformément aux objectifs de la stratégie de Lisbonne, chaque Etat membre de l’Union européenne doit consacrer à l’horizon 2010 3 % de son PIB aux activités de R&D. Or qu’en est-il outre-Rhin ? Via une approche comparative internationale, Ulrich Schmoch, chef de projets à l’Institut Fraunhofer de recherche sur les systèmes et l’innovation (ISI) de Karlsruhe, révèle dans un premier temps l’origine institutionnelle et sectorielle des dépenses de R&D. Sa contribution permet par la suite d’identifier les différents acteurs du système de recherche et d’innovation allemand ainsi que les défis qui se posent à eux, avec une attention particulière portée sur les centres de recherche extra-universitaires (Instituts Fraunhofer, Instituts Max-Planck…), les établissements d’enseignement supérieur et les instituts dits associés (An-Institute)